Natixis’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
Other funds holding CCXI
Natixis's CCXI Position: Q4 2022 in Review
Natixis sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 99,206 shares — an estimated $5.13M sold.
Natixis first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $5.13M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Natixis reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Natixis sold 99,206 ChemoCentryx, Inc. shares in Q4 2022, an estimated $5.13M.
- Natixis first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
- Natixis's ChemoCentryx, Inc. position peaked at $5.13M in Q3 2022.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Natixis's 13F filing for Q4 2022, filed 13 Feb 2023.